Cellcolabs
Biotech impact start-up specializing in production of high-quality stem cells
Advanced cell therapies will disrupt health care as we know it. Application opportunities are almost limitless. However, there is a shortage of cells manufactured according to full Good Manufacturing Practice (GMP) compliance on the global market – both for clinical trials and treatments. That's why Cellcolabs was founded in 2021.
Cellcolabs is a biotech company specializing in industrial GMP production of high quality stem cells (mesenchymal stromal cells) in order to make them available at scale. Our ultimate goal is to accelerate stem cell research and make the treatments of the future available for all.
Visit website: https://cellcolabs.com/
Details last updated 31-Mar-2023
People at Cellcolabs
Cellcolabs News
Stem cell therapy shows promise in slowing ageing and preventing disease
Newsweek - 29-Sep-2024
Mesenchymal stem cells may revolutionize healthcare by combating inflammation and ageing
Read more...